Association of Body Composition Parameters with the Short- and Long-Term Efficacy of Neoadjuvant Immunotherapy Combined with Chemotherapy in Advanced Gastric Cancer

化疗 免疫疗法 医学 癌症 肿瘤科 内科学 期限(时间) 联想(心理学) 新辅助治疗 心理学 量子力学 物理 乳腺癌 心理治疗师
作者
Bingyan Cao,Peifang Zhang,Zhanying Shi
出处
期刊:Nutrition and Cancer [Routledge]
卷期号:77 (4-5): 455-464 被引量:4
标识
DOI:10.1080/01635581.2025.2455762
摘要

Background Immunotherapy has become a prevalent strategy in the neoadjuvant treatment of advanced gastric cancer (AGC). This study investigates the predictive value of computed tomography (CT)-derived body composition parameters on the efficacy of neoadjuvant immunotherapy for AGC.Methods Data on 103 patients with resectable AGC who received neoadjuvant immunotherapy combined with chemotherapy at a teaching hospital between March 2020 and August 2022 were collected. Body composition parameters, including the subcutaneous adipose index (SAI), visceral adipose index (VAI), and skeletal muscle index (SMI), were calculated from pretreatment CT images. Logistic regression and Cox proportional hazards models assessed the impact of these parameters on pathological responses and survival outcomes following treatment.Results Of the patients, 34 (33.0%) achieved a major pathological response (MPR). Higher SAI, VAI, and SMI values were significantly linked to an increased likelihood of achieving MPR (p < 0.05). Multivariate regression analysis revealed that only SAI independently predicted MPR (OR 1.042, 95% CI 1.009–1.077, p = 0.013). Furthermore, patients with a high SAI had significantly improved 2-year overall survival (76.9% vs. 54.9%, log-rank p = 0.012) and 2-year event-free survival (71.2% vs. 51.0%, log-rank p = 0.022) compared to those with low SAI. The survival benefit associated with high SAI was partly due to its higher MPR rate (mediating proportion: 37.5%, 95% CI: 12%–110%).Conclusion Pretreatment SAI independently correlates with MPR and better oncological outcomes in patients with AGC receiving neoadjuvant immunotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZEcholy完成签到,获得积分10
1秒前
yansiyi发布了新的文献求助10
1秒前
xiaofengyyy完成签到,获得积分10
2秒前
1111发布了新的文献求助10
2秒前
Orange的应助被xhy777采纳,获得10
2秒前
xixihaha完成签到,获得积分10
2秒前
王德荣完成签到,获得积分10
3秒前
不安寒风完成签到,获得积分10
3秒前
Su完成签到 ,获得积分10
4秒前
脑洞疼的应助被Lee采纳,获得10
4秒前
电风扇完成签到,获得积分10
5秒前
zxcharm完成签到,获得积分0
5秒前
Jared发布了新的文献求助10
5秒前
我是谁的应助被哈哈镜阿姐采纳,获得30
6秒前
7秒前
Yob完成签到,获得积分10
7秒前
乐乐的应助被zyy采纳,获得30
8秒前
规划计划完成签到 ,获得积分10
8秒前
科研通AI6.2的应助被tjl采纳,获得10
9秒前
邱燈完成签到,获得积分10
10秒前
SciGPT的应助被外向的大狮子采纳,获得10
11秒前
11秒前
天天快乐的应助被6666采纳,获得10
11秒前
伶俐绿柏完成签到,获得积分10
12秒前
12秒前
传奇3的应助被JF123_采纳,获得10
12秒前
Owen的应助被yansiyi采纳,获得20
13秒前
eerrtt完成签到,获得积分10
14秒前
14秒前
14秒前
松下完成签到,获得积分10
14秒前
15秒前
打打的应助被廖翰彬采纳,获得10
15秒前
15秒前
Qiiiyoung完成签到,获得积分10
15秒前
张远幸发布了新的文献求助10
16秒前
16秒前
16秒前
peng完成签到,获得积分10
16秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820